HRT FINANCIAL LP

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1475597 NEW YORK, NY

Position in AUPH

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$3,127,390

+$1,815,758 QoQ

Shares Held

211,025

+156.6% QoQ

Ownership

0.164%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $416,760,191 across 198 Biotechnology names. AUPH ranks #34 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	128,633	$42,560,800
2	IBRX	ImmunityBio, Inc.	3,925,446	$30,108,170
3	EXEL	Exelixis, Inc.	460,585	$19,754,490
4	IONS	Ionis Pharmaceuticals Inc	252,250	$18,941,452
5	MRNA	Moderna, Inc.	368,421	$18,715,786
6	ARGX	Argenx SE	18,754	$13,695,108
7	RARE	Ultragenyx Pharmaceutical Inc.	613,229	$12,847,147
8	IOVA	Iovance Biotherapeutics, Inc.	3,486,299	$12,236,909

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,127,390	211,025	+156.6%	Shares	Defined	2026-05-14
2025-12-31	$1,311,632	82,234	+101.4%	Shares	Defined	2026-02-12
2025-09-30	$451,282	40,840	+32.8%	Shares	Defined	2025-11-14
2023-12-31	$276,541	30,761	-10.9%	Shares	Defined	2024-02-09
2023-09-30	$268,344	34,536	-67.2%	Shares	Defined	2023-11-13
2023-06-30	$1,018,558	105,223	+16.8%	Shares	Defined	2023-08-11
2023-03-31	$987,112	90,065	+132.4%	Shares	Defined	2023-05-12
2022-03-31	$479,786	38,755	-60.0%	Shares	Defined	2022-05-16
2021-06-30	$1,255,720	96,892	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.